Exposomics

Mold exposure and chronic illness.

Mold exposure from water-damaged buildings is a real cause of chronic illness in a subset of patients. The diagnosis is overcalled in the wellness world and underrecognized in conventional medicine. The honest middle is where the clinical work happens.

Daniel Tagge, MD4 min read

Mold exposure is one of those topics where the conventional medical world and the functional medicine world have drifted into nearly opposite positions. Conventional medicine often dismisses it. Functional medicine often blames it for everything. Both extremes are wrong.

The honest clinical reality: mold exposure from water-damaged buildings is a real cause of significant chronic illness in a measurable subset of patients. It is also overdiagnosed in patients with vague symptoms who happened to have visible mold somewhere in their lives. The diagnostic work matters.

What we know is real

Several connections are well-established.

Allergic responses to mold spores. Common, well-characterized, presents as classic allergy or asthma symptoms. Treatable with standard approaches.

Direct infection in immunocompromised patients. Aspergillus and other species can cause serious infection. This is a hospital-relevant scenario, not a wellness question.

Hypersensitivity pneumonitis. A specific lung inflammatory response to repeated mold exposure. Treatable when identified and the exposure is removed.

Chronic Inflammatory Response Syndrome (CIRS). The diagnosis Dr. Ritchie Shoemaker described in patients with biotoxin exposure, often from water-damaged buildings. Characterized by specific patterns on inflammatory markers and a constellation of symptoms. The diagnosis is real in patients who actually have it, and the protocols for treatment have been refined over two decades.

Mycotoxin exposure with specific health effects. Aflatoxin, ochratoxin, and others have established health effects at sufficient exposure. The clinical question is dose and duration.

What is often overcalled

The pattern I see most often: a patient with chronic fatigue, brain fog, and inflammatory symptoms has visible mold somewhere in their environment and gets a mold diagnosis without rigorous workup. The mold may or may not be the actual driver. Without testing, you cannot tell.

The cost of misdiagnosis is significant. Patients spend years on aggressive mold protocols, expensive home remediation, and elimination diets, when the actual driver might be metabolic, hormonal, gut-related, or something else entirely.

The workup I order when mold is in the differential

For a patient with chronic illness and a credible mold exposure history (water-damaged building, visible moisture, history of basement living, persistent musty smell), the workup includes:

  1. Urinary mycotoxin panel. Reads specific mycotoxins the body is currently excreting. Useful for identifying current or recent exposure.
  2. MARCoNS culture. If sinus symptoms are significant. Antibiotic-resistant biofilm colonization of the nasal passages is part of the CIRS picture.
  3. Standard inflammatory panel. hsCRP, TGF-beta, MMP-9, and the specific markers Shoemaker described.
  4. Comprehensive metabolic and hormone workup. To rule in or rule out the other drivers.
  5. Visual contrast sensitivity test. A screening tool for biotoxin-related neurological involvement.
  6. Environmental assessment. Often the most important step. An ERMI test of the building, professional mold inspection, or both.

The pattern across these tells me whether mold is the primary driver, a contributing factor, or essentially absent from the case.

What the intervention looks like

When the diagnosis is supported:

Remove the exposure. This is non-negotiable. Continuing to live in the source environment defeats all other treatment. Sometimes this means significant remediation; sometimes it means moving.

Support detoxification. Glutathione precursors (NAC, glycine), often binders (cholestyramine in CIRS protocols, sometimes activated charcoal, bentonite clay). Methylated B vitamins to support clearance.

Address the inflammatory cascade. Anti-inflammatory diet, omega-3s, sometimes targeted pharmaceuticals.

Treat MARCoNS if present.

Slow phased recovery. CIRS patients often have prolonged recovery measured in months. The protocol works but it is not fast.

When mold is not the answer

If the workup does not support mold as a primary driver, I move on to the other possibilities. Most chronic illness has multiple contributing factors; mold is one possible variable, not a default explanation.

What this is not

I am not telling patients to ignore mold concerns. I am not selling a mold protocol. I am also not blaming mold for vague chronic symptoms without the workup that supports it.

If you have a credible mold exposure history and want a physician to read whether the picture supports mold as a driver, the path in is the Precision Call.

Dr. Daniel Tagge, MD

Written by

Daniel Tagge, MD

Board-certified family physician. North Carolina’s only physician certified in Health Optimization Medicine. Third-generation physician. NPI 1225562218.

About Dr. Tagge

Bring it to the practice

Want this read for your biology?

A complimentary 30-minute call, phone or video. With me, not a coordinator. I tell you what I see in your case and how I would work it.

More on exposomics

Read alongside.